A low-cost, portable multispectral NIRS platform can enable trend monitoring and early warning of perfusion compromise in settings in which conventional devices are impractical.
Vyas et al. (Thu,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: